ClinicalTrials.gg
CompletedNCT06781164TMED_FOG_001Updated Jan 17, 2025

Examination of the Applicability and Performance of Otolaryngology Telemedicine, Telediagnostics in Establishing the Diagnosis and Therapy of Otolaryngology Diseases

An interventional study of telemedicine in Ear Infection and Telemedicine, sponsored by Szeged University. Completed at 1 site in Hungary. Open to participants aged 6 Years and older. Per ClinicalTrials.gov, last updated 2025-01-17.

Sponsored by Szeged University · Not applicable, Interventional, and Diagnostic

From the registry’s dates

  • Registered 4 years 8 months after the study started (first participant enrolled Apr 2020, registered Dec 2024).
Phase
Not applicable
Study type
Interventional
Enrollment
103
Allocation
Not applicable
Ages
6 Years and older
Sex
All
01

Study summary

System/Device name: Otoscopic recording and clinical data telemedicine software supporting its transmission and analysis.

Characteristics of the medical device:

The device is applied to an iPhone with a CE mark also from a CE-marked optical unit and the system operator, a consists of software under investigation.

Read the detailed description

The detailed operation is in the user guide in Hungarian included. The device makes a video recording of the external ear canal and about the tympanic membrane, and it records clinical data (symptoms, complaints).

The telephone application sends the data through the system to a doctor, who, by analyzing them, makes a diagnosis and provides therapy.

The study is a prospective, single-arm study. The specialist treating the real patient (called doctor 2) does not see or know the diagnosis and the therapy from the telemedicine system, or the recommendation from the telemedicine The diagnosis and therapeutic treatment established by the two methods are evaluated by an independent specialist and decides whether the primary diagnosis and therapeutic treatment are the same or not in the telemedicine system.

02

Conditions studied

  • Ear Infection
  • Telemedicine

Browse trials for

03

In context

Otitis

80 studies on the registry are indexed under Otitis; 10 are open to participants now.

This study's enrollment of 103 is below the median of 183 across 54 interventional studies indexed under Otitis.

Browse Otitis studies →

Lead sponsor

Szeged University is the lead sponsor of 56 studies on the registry; 8 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
6 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Signed form
  • Patients with ear complaints (especially, but not exclusively, ear pain from the ear discharge, itching, cerumen accumulation,)
  • The subject communicates well with the investigator and is able to understand the requirements of the test plan and to help with compliance.

Exclusion criteria

Exclusion Criteria:

  • Poor general condition
  • Based on the investigator's decision, a condition that directly threatens life or a symptom that corresponds to these may indicate (e.g.: Liquor dripping, massive bleeding, etc.)
  • Any disease that, in the investigator's opinion, endangers the patient's health and/or contraindicates performing the test
  • The examiner finds that further participation is a disadvantage for the patient for any reason;
  • the patient requests the suspension of his participation orally or in writing
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
103 participants (actual)

Study arms

  • Experimental
    telemedicine arm

    A recording of the ear of each patient with an ear problem was taken with the device, and then they were diagnosed and prescribed therapy in the traditional way.

    Device: telemedicine

Interventions

  • Devicetelemedicine

    Recording of the ear of each patient with an ear problem

06

What researchers measure

Primary outcomes

  1. Comparison of the diagnoses treatments made by remote diagnostics and an on-site specialist.

    The primary objectives of the study is: number of matching cases, measured with the similarity and matching of International Classification of Diseases (ICD) codes.

    Time frame: 1 day

  2. Comparison of therapy

    Matching or similarity of prescribed therapy, e.g. same family of antibiotics , or the type of active substance. The match based on Anatomical Therapeutic Chemical (ATC) Classification

    Time frame: 1 day

07

Study locations

1 site
  • Otorhinolaryngology and Head and Neck Surgery Clinic
    Szeged, Csongrád 6720, Hungary
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 17, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06781164
Lead sponsor
Szeged University
Collaborators
University of Szeged, Hungary
Responsible party
Sponsor
First posted
Jan 17, 2025
Start date
Apr 1, 2020
Primary completion
May 23, 2023
Completion
May 31, 2023
Last update
Jan 17, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion